Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Song, No Joon ^a   Yun, Ui Jeong ^a   Yang, Sunghee ^a   Wu, Chunyan ^b   Seo, Cho Rong ^a   Gwon, A Ryeong ^a,c   Baik, Sang Ha ^a   Choi, Yuri ^a   Choi, Bo Youn ^a   Bahn, Gahee ^a   Kim, Suji ^a   Kwon, So Mi ^a   Park, Jin Su ^a   Baek, Seung Hyun ^a   Park, Tae Joo ^d   Yoon, Keejung ^a   Kim, Byung Joon ^c   Mattson, Mark P ^e   Lee, Sung Joon ^b   Jo, Dong Gyu ^a   Park, Kye Won ^a   more..

^a Sungkyunkwan University   (South Korea)

^b Korea University   (South Korea)

^c Gachon University   (South Korea)

^d Ulsan National Institute of Science and Technology   (South Korea)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; NOTCH1 RECEPTOR;

ADIPOCYTE; ADVERSE EFFECTS; ANIMAL; CELL LINE; DEFICIENCY; DIET; DRUG EFFECTS; FATTY LIVER; GENE SILENCING; GENETICS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; METABOLISM; MOUSE; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; CELL LINE; DIET; FATTY ACIDS; FATTY LIVER; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MICE; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; RECEPTOR, NOTCH1; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84955266039     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19377     Document Type: Article

References (32)

1. Kahn, B. B. & Flier, J. S. Obesity and insulin resistance. The Journal of clinical investigation 106, 473-481 (2000).
2. Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L. & Brown, M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378, 815-825 (2011).
3. Kopelman, P. G. Obesity as a medical problem. Nature 404, 635-643 (2000).
4. Waki, H. & Tontonoz, P. Endocrine functions of adipose tissue. Annual review of pathology 2, 31-56 (2007).
5. Tontonoz, P. & Spiegelman, B. M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77, 289-312 (2008).
6. Hong, J. W. & Park, K. W. Further understanding of fat biology: lessons from a fat fly. Exp Mol Med 42, 12-20 (2010).
7. Rosen, E. D. et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4, 611-617 (1999).
8. Rosen, E. D. & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7, 885-896 (2006).
9. Perdigoto, C. N. & Bardin, A. J. Sending the right signal: Notch and stem cells. Biochim Biophys Acta 1830, 2307-2322 (2012).
10. Selkoe, D. & Kopan, R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26, 565-597 (2003).
11. Park, J. S. et al. Inhibition of Notch signalling ameliorates experimental inflammatory arthritis. Ann Rheum Dis (2013).
12. Arumugam, T. V. et al. Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nature medicine 12, 621-623 (2006).
13. Fortini, M. E. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 16, 633-647 (2009).
14. Pajvani, U. B. et al. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nature medicine 17, 961-967 (2011).
15. Fowler, J. C., Zecchini, V. R. & Jones, P. H. Intestinal activation of Notch signaling induces rapid onset hepatic steatosis and insulin resistance. PLoS One 6, e20767 (2011).
16. Pajvani, U. B. et al. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nature medicine 19, 1054-1060 (2013).
17. Cheng, P. et al. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 167, 4458-4467 (2001).
18. Wang, Y. et al. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci USA 101, 9458-9462 (2004).
19. Woo, H. N., Park, J. S., Gwon, A. R., Arumugam, T. V. & Jo, D. G. Alzheimer's disease and Notch signaling. Biochemical and biophysical research communications 390, 1093-1097 (2009).
20. Jung, S. R. et al. Silk proteins stimulate osteoblast differentiation by suppressing the Notch signaling pathway in mesenchymal stem cells. Nutr Res 33, 162-170 (2013).
21. Garces, C. et al. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272, 29729-29734 (1997).
22. Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. The Journal of clinical investigation 114, 147-152 (2004).
23. Koo, S. H. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19, 210-215 (2013).
24. Cherkaoui-Malki, M., Surapureddi, S., El-Hajj, H. I., Vamecq, J. & Andreoletti, P. Hepatic steatosis and peroxisomal fatty acid betaoxidation. Curr Drug Metab 13, 1412-1421 (2012).
25. Kawano, Y. & Cohen, D. E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 48, 434-441 (2013).
26. Yen, C. L., Stone, S. J., Koliwad, S., Harris, C. & Farese, R. V., Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49, 2283-2301 (2008).
27. Vluggens, A. & Reddy, J. K. Nuclear receptors and transcription factors in the development of fatty liver disease. Curr Drug Metab 13, 1422-1435 (2012).
28. Lei, K. J. et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet 13, 203-209 (1996).
29. Chou, J. Y. & Mansfield, B. C. Gene therapy for type I glycogen storage diseases. Curr Gene Ther 7, 79-88 (2007).
30. Mutel, E. et al. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol 54, 529-537 (2011).
31. Song, N. J. et al. Butein is a novel anti-adipogenic compound. J Lipid Res 54, 1385-1396 (2013).
32. Seo, C. R. et al. Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. Food Chem Toxicol 64, 217-224 (2014).